Opthea Stock Analysis

Opthea Stock Analysis Notes

The company recorded a loss per share of 2.76. Opthea had not issued any dividends in recent years. The entity had 5:8 split on the 15th of October 2020. Opthea Limited, a clinical stage biopharmaceutical company, develops and commercializes therapies primarily for eye disease in Australia. Opthea Limited was incorporated in 1984 and is based in South Yarra, Australia. Opthea operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. To find out more about Opthea contact MAICD MAICD at 61 3 9826 0399 or learn more at https://opthea.com.

Opthea Investment Alerts

Opthea Upcoming and Recent Events

Opthea Largest EPS Surprises

View All Earnings Estimates

Opthea Environmental, Social, and Governance (ESG) Scores

Opthea Stock Institutional Investors

Note, although Opthea's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Opthea Market Capitalization

The company currently falls under 'Small-Cap' category with a total capitalization of 543.93 M.

Opthea Profitablity

Management Efficiency

Opthea has Return on Asset of (0.8343) % which means that on every $100 spent on assets, it lost $0.8343. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (33.8308) %, meaning that it generated no profit with money invested by stockholders. Opthea's management efficiency ratios could be used to measure how well Opthea manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -1.22 in 2024. Return On Capital Employed is likely to gain to -1.46 in 2024. At this time, Opthea's Total Current Liabilities is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 198.2 M in 2024, whereas Non Current Liabilities Other is likely to drop slightly above 39.8 M in 2024.

Technical Drivers

As of the 29th of November, Opthea holds the Semi Deviation of 3.91, coefficient of variation of 1544.52, and Risk Adjusted Performance of 0.0578. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Opthea, as well as the relationship between them.

Opthea Price Movement Analysis

Opthea Outstanding Bonds

Opthea Predictive Daily Indicators

Opthea Corporate Filings

Opthea Forecast Models

Opthea's time-series forecasting models are one of many Opthea's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Opthea's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Opthea prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Opthea shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Opthea. By using and applying Opthea Stock analysis, traders can create a robust methodology for identifying Opthea entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Opthea analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Opthea analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Opthea stock analysis indicators help investors evaluate how Opthea stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Opthea shares will generate the highest return on investment. By understating and applying Opthea stock analysis, traders can identify Opthea position entry and exit signals to maximize returns.

When running Opthea's price analysis, check to measure Opthea's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Opthea is operating at the current time. Most of Opthea's value examination focuses on studying past and present price action to predict the probability of Opthea's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Opthea's price. Additionally, you may evaluate how the addition of Opthea to your portfolios can decrease your overall portfolio volatility.